Status: Not yet recruiting
Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion
The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB in patients with long femoropopliteal lesions who underwent percutaneous transluminal angioplasty using GENOSS PCB.
Participants needed: 300
Trial details
Age: 19-85Biological sex: AllType: ObservationalSponsor: Genoss Co., Ltd.Updated: Feb 20, 2026Locations: 1
Eligibility criteria
Subject was ≥19 years of age. [+5]
Subjects was allergic to paclitaxel. [+9]